Trial intelligence / Profile preview

Medication vs Meditation for Knee Osteoarthritis

NCT07837284Phase 1Not yet recruiting

Sponsor
Florida State University
Start
Jan 2027
Primary completion
Oct 2027
01

Overview

Phase 1, randomised, open-label trial of diclofenac in knee osteoarthritis (OA) (2 arms), sponsored by Florida State University. Primary endpoints: Feasibility of Recruitment and Enrollment at 6 months, Theoretical Framework of Acceptability Questionnaire at 33 days and 2 more. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

diclofenac
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07837284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07837284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call